Literature DB >> 15768835

Recognition of patients with cardiovascular disease by artificial neural networks.

Damiano Baldassarre1, Enzo Grossi, Massimo Buscema, Marco Intraligi, Mauro Amato, Elena Tremoli, Linda Pustina, Samuela Castelnuovo, Silvia Sanvito, Lorenzo Gerosa, Cesare R Sirtori.   

Abstract

BACKGROUND: Artificial neural networks (ANNs) are computer algorithms inspired by the highly interactive processing of the human brain. When exposed to complex data sets, ANNs can learn the mechanisms that correlate different variables and perform complex classification tasks. AIMS: A database, of 949 patients and 54 variables, was analysed to evaluate the capacity of ANNs to recognise patients with (VE+, n = 196) or without (VE-, n = 753) a history of vascular events on the basis of vascular risk factors (VRFs), carotid ultrasound variables (UVs) or both.
METHOD: The performance of ANN was assessed by calculating the percentage of correct identifications of VE+ and VE- patients (sensitivity and specificity, respectively) and the prediction accuracy (weighted mean between sensitivity and specificity).
RESULTS: The results showed that ANNs can be trained to identify VE+ and VE- subjects more accurately than discriminant analyses. When VRFs and UVs were used as input variables, the prediction accuracies of the ANN providing the best results were 80.8% and 79.2%, respectively. The addition of gender, age, weight, height and body mass index to UVs increased accuracy of prediction to 83.0%. When the ANNs were allowed to choose the relevant input data automatically (I.S. system-Semeion), 37 variables were selected among 54, five of which were UVs. Using this set of variables as input data, the performance of the ANNs in the classification task reached a prediction accuracy of 85.0%. with the 92.0% correct classification of VE+ patients.
CONCLUSIONS: Artificial neural network technology is highly promising in the development of accurate diagnostic tools designed to recognize patients at high risk of cardiovascular diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15768835     DOI: 10.1080/07853890410018880

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  5 in total

1.  Prediction of persistence of combined evidence-based cardiovascular medications in patients with acute coronary syndrome after hospital discharge using neural networks.

Authors:  Valérie Bourdès; Jean Ferrières; Jacques Amar; Elisabeth Amelineau; Stéphane Bonnevay; Maryse Berlion; Nicolas Danchin
Journal:  Med Biol Eng Comput       Date:  2011-05-20       Impact factor: 2.602

2.  The Framingham study and treatment guidelines for stroke prevention.

Authors:  Enzo Grossi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

3.  Development of a method based on surface enhanced laser desorption and ionization time of flight mass spectrometry for rapid identification of Klebsiella pneumoniae.

Authors:  Daiwen Xiao; Yongchang Yang; Hua Liu; Hua Yu; Yingjun Yan; Wenfang Huang; Wei Jiang; Weijin Liao; Qi Hu; Bo Huang
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

4.  How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods.

Authors:  Enzo Grossi
Journal:  BMC Cardiovasc Disord       Date:  2006-05-03       Impact factor: 2.298

5.  Placental determinants of fetal growth: identification of key factors in the insulin-like growth factor and cytokine systems using artificial neural networks.

Authors:  Maria E Street; Enzo Grossi; Cecilia Volta; Elena Faleschini; Sergio Bernasconi
Journal:  BMC Pediatr       Date:  2008-06-17       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.